Position
Fidelity in Generate Biomedicines, Inc.
Back to the book · All holders of GENB
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $18.4M$12.50 → $16.87
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q1 2026 | 4.22M | $52.7M | — | — | — | 0.0% |
| Q2 2026 | 5.22M | $88.1M | $16.87 | $18.4M | $16.9M | 0.0% |